The Federal Trade Commission and its U.K. counterpart concluded that Roche would not likely have an incentive to delay or discontinue development of Spark’s hemophilia A gene therapy. Roche markets a monoclonal antibody for the same disease.
The mandatory CMS TEAM program begins next year. Are you ready? As hospitals consider their options for addressing the mandate, here are some actions to…
For many people, migraines interfere with daily life, work and relationships. Understanding what’s behind them — and how to manage them naturally — can be…
The status quo for medical malpractice insurance is no longer good enough. While we must always prioritize the need for accountability when it comes to…
Discover what tools are essential for efficient, safe surgical extractions in today’s health care landscape, from elevators to forceps and beyond.
EMS providers often treat patients without medical history, risking delays, errors, and guesswork. But new national data-sharing frameworks are starting to close that gap, bringing…
There were only five hospital M&A transactions during the first quarter of 2025 — a slump caused the Trump administration’s flurry of new policies and…
A federal court judge ruling leaves in place an FDA determination that shortages of the Novo Nordisk drugs Wegovy and Ozempic are resolved. Consequently, compounding…
Many of those who survive the loss, devastation, and displacement of an extreme climate event — such as a flood, tornado, drought, or wildfire —…
The layout of your phlebotomy station can significantly impact efficiency. A well-thought-out setup ensures that every tool is within reach, minimizing unnecessary movement and reducing…
Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. Medtronic has a commercialization deal with the company for the…
